Details for Patent: 7,560,429

✉ Email this page to a colleague

Which drugs does patent 7,560,429 protect, and when does it expire?

Patent 7,560,429 protects NOCDURNA and is included in one NDA.

This patent has forty-three patent family members in twenty-nine countries.

Summary for Patent: 7,560,429

Title:	Orodispersible dosage forms of desmopressin acetate
Abstract:	Good bioavailability of desmopressin can be obtained by means of an orodispersible pharmaceutical dosage form. Preferred dosage forms comprise desmopressin and an open matrix network which is an inert water-soluble or water-dispersible carrier material. Desmopressin formulated in this way is useful for voiding postponement, or the treatment or prevention of incontinence, primary nocturnal enuresis (PNE), nocturia or central diabetes insipidus. Peptides other than desmopressin can also be formulated in this way.
Inventor(s):	Nilsson; Anders (Lund, SE), Lindner; Hans (Leichlingen, DE), Wittendorff; Jorgen (Hvidovre, DK)
Assignee:	Ferring B.V. (Hoofddorp, NL)
Application Number:	10/513,437
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,560,429
Patent Claim Types: see list of patent claims	Use; Composition; Formulation; Process; Dosage form;

Drugs Protected by US Patent 7,560,429

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Ferring Pharms Inc	NOCDURNA	desmopressin acetate	TABLET;SUBLINGUAL	022517-001	Jun 21, 2018		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS	⤷ Sign Up
Ferring Pharms Inc	NOCDURNA	desmopressin acetate	TABLET;SUBLINGUAL	022517-002	Jun 21, 2018		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up	Y			TREATMENT OF NOCTURIA DUE TO NOCTURNAL POLYURIA IN ADULTS	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 7,560,429

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	0210397.6	May 7, 2002
	PCT/IB02/04036	Sep 20, 2002

PCT Information
PCT Filed	May 07, 2003	PCT Application Number:	PCT/IB03/02368
PCT Publication Date:	November 20, 2003	PCT Publication Number:	WO03/094886

International Family Members for US Patent 7,560,429

Subscribe to access the full database, or Sign Up
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	039092	⤷ Sign Up
Argentina	039794	⤷ Sign Up
Argentina	107948	⤷ Sign Up
Austria	333886	⤷ Sign Up
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.